(Press-News.org) SPOKANE, Wash. – Families that participated in the WIC program—also known as the Special Supplemental Nutrition Program for Women, Infants and Children—were much less likely to use potentially unsafe infant feeding practices during the 2022 U.S. infant formula shortage than income-eligible families that did not participate.
Both WIC participants and non-participants reported being affected by the shortage at similar rates, according to a Washington State University study published in the Journal of the Academy of Nutrition and Dietetics. However, the researchers found that WIC participants were significantly more likely to cope with the shortage by changing the brand or type of formula or by getting it from a different source. They were also less likely to use less healthy feeding practices, such as using dairy milk or milk alternatives, watering down formula or using homemade formula.
“WIC provides a safety net for infants and children, and early childhood WIC participation has long-lasting benefits for health, wellbeing and academic achievement,” said Namrata Sanjeevi, the study’s first author and a research associate in WSU’s Elson S. Floyd College of Medicine. “By examining how WIC participation could be related to infant feeding practices during the formula shortage, our study adds important findings on how WIC can support families during times of crisis.”
The study evaluated how participation in WIC impacted families’ experiences and coping strategies during the monthslong shortage, which started in February 2022 when a manufacturer recall added to existing pandemic-related supply chain issues. A federal nutrition assistance program that provides free formula and essential nutritious foods to low-income families, the WIC program serves more than 1.4 million babies, about half of whom were receiving formula produced by the affected manufacturer.
Although data on why respondents selected specific coping strategies were not available, Sanjeevi said these findings provide some evidence that more flexible WIC policies may have eased the burden on participating families during the shortage. Following the manufacturer recall, the federal government temporarily waived restrictions on WIC benefits that limited participants as to the type, size and brand of formula they could obtain. Sanjeevi believes the improved access provided by these waivers—most of which were in place through at least the end of 2022—may have kept WIC participants from using undesirable feeding practices. In addition, she said the program could have protected participants from the budget impact of surging formula prices, since formula is provided to them free of cost.
Data for the study came from the Household Pulse Survey, an online survey designed to measure U.S. household experiences during the COVID-19 pandemic, and were collected between December 2022 and February 2023. The researchers’ analysis is based on data provided by 1,542 respondents whose household income was at or below 185% of federal poverty level—the threshold for WIC participation—and who had children younger than 18 months. Out of those respondents, 881, or just under 60%, reported participating in WIC.
Senior study author Pablo Monsivais, an associate professor in the WSU College of Medicine, said this is consistent with federal statistics that suggest that only about half of the women who are eligible for WIC are enrolled in the program.
“We need to do more to understand and eliminate barriers that keep families from participating in this proven, cost-effective program,” said Monsivais, adding that research has shown that every dollar invested in the program saves almost $2.50 in medical, educational and productivity costs.
“WIC has been put under the microscope again and again,” he said. “Our study adds to the growing body of evidence that the program protects the health and wellbeing of low-income families and makes good economic sense.”
END
WIC participation helped families better cope with 2022 infant formula shortage
2023-12-07
ELSE PRESS RELEASES FROM THIS DATE:
Early life gene epimutation may cause breast cancer.
2023-12-07
Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of normal tissue cells carrying an epimutation of a specific gene.
Cancer is a major health challenge worldwide, affecting many lives. Despite progress in understanding its causes, most cancer forms, including breast cancer, continues to increase in ...
The mechanism of ferroptosis and its related diseases
2023-12-07
In a groundbreaking review titled "The Mechanism of Ferroptosis and its Related Diseases," Feng and his colleagues from the Department of Urology and the Institute of Urology, State Key Laboratory of Biotherapy, and Cancer Center at West China Hospital, Sichuan University, have undertaken a comprehensive investigation of ferroptosis and its intricate relationships with various diseases. This review not only discusses the mechanisms of ferroptosis and its associations with diseases but also underscores the pivotal role of compounds in targeting this regulated cell death process for therapeutic applications.
Ferroptosis, initially identified by Dr. Brent R. Stockwell in 2012, gained ...
X-ray method enables micron-resolution imaging of living organisms over long time periods
2023-12-07
WASHINGTON — Researchers have developed an X-ray imaging technique that can produce detailed images of living organisms with a much lower X-ray dose than previously possible. The advance enables small organisms or other sensitive samples to be studied at high resolution over much longer periods, which could reveal new insights into a variety of dynamic processes.
The approach is based on phase contrast imaging, which relies not only on the absorption of X-rays in a sample, but also on the wave properties ...
Exercise may boost quality of life for patients with metastatic breast cancer
2023-12-07
SAN ANTONIO – Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise program reported less fatigue and an improved quality of life compared to those who did not undergo the exercise program, according to results from the PREFERABLE-EFFECT trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Breast cancer and its treatments can cause side effects, such as fatigue, nausea, pain, and shortness of breath, which can decrease a patient’s health-related quality of life (HR-QoL). For patients with metastatic ...
Patients with HR-positive breast cancer may use fertility preservation and assisted reproductive technologies without increased risk of recurrence
2023-12-07
Using fertility preservation and/or assisted reproductive technologies (ART) did not adversely impact three-year cancer recurrence rates among patients with hormone receptor (HR)-positive breast cancer who paused endocrine therapy to become pregnant, according to results from the POSITIVE trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
“With the increasing age of childbearing, it is becoming more likely that women will be diagnosed with breast cancer before starting or completing their families,” said Hatem A. Azim Jr., MD, ...
Younger postmenopausal patients with early-stage breast cancer may be able to safely omit adjuvant radiotherapy
2023-12-07
SAN ANTONIO – Almost all postmenopausal patients aged 50-69 years with stage I hormone receptor (HR)-positive breast cancer and low scores on a common genetic test who opted out of adjuvant radiotherapy were disease free five years after surgery, according to results from the IDEA clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Results were simultaneously published in the Journal of Clinical Oncology.
Patients who are diagnosed with stage I HR-positive breast cancer typically undergo breast-conserving surgery followed by adjuvant radiotherapy and endocrine therapy to reduce ...
Using machine learning to monitor driver ‘workload’ could help improve road safety
2023-12-07
Researchers have developed an adaptable algorithm that could improve road safety by predicting when drivers are able to safely interact with in-vehicle systems or receive messages, such as traffic alerts, incoming calls or driving directions.
The researchers, from the University of Cambridge, working in partnership with Jaguar Land Rover (JLR) used a combination of on-road experiments and machine learning as well as Bayesian filtering techniques to reliably and continuously measure driver ‘workload’. Driving in an unfamiliar area may translate ...
Manipulation of gut microbiota with flaxseed could reduce breast cancer risk
2023-12-07
Washington, D.C.— A new study demonstrates that the human gut microbiome may be a factor in breast health. Lifestyle and diet have long been known to affect human health. In the study, flaxseed components called lignans were shown to influence the relationship between gut microorganisms and the expression of mammary gland microRNAs (miRNAs). A subset of these miRNAs regulates the genes involved in breast cancer, including genes that control cell proliferation and migration. The study was published in Microbiology Spectrum, a journal of the American Society for Microbiology.
“The ...
Most of the world’s countries receive failing grade in global ‘human rights report card’
2023-12-07
KINGSTON, R.I. —Dec. 7, 2023—A new report that grades all the countries of the world on their respect for human rights paints a grim picture of human rights practices in the 21st century.
Produced by the Global RIghts Project (GRIP), a research team based in the University of Rhode Island’s Center for Nonviolence and Peace Studies, the report draws on a vast quantitative human rights dataset to grade each country’s human rights practices on a 100-point scale. The report found that 60% of the world’s countries get an ‘F’ (a ...
EU funds research into causes and new therapies for multiple sclerosis
2023-12-07
Multiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide. MS is characterized by an inflammation-related loss and damage of the myelin layer in the brain and spinal cord, which insulates the nerves – potentially leading to serious consequences such as paralysis or severe visual impairment.
The cause of this damage is not known. Viral infections, particularly with the Epstein-Barr virus, have been suspected for years. However, ...